Details of the Drug

General Information of Drug (ID: DM02MRW)

• Drug Name: Remestemcel-L
• Synonyms: MSC-100-IV

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Phase 3	[1]
Graft-versus-host disease	4B24	Phase 3	[2]

• Affected Organisms: Humans and other mammals
• Drug Type: Cell therapy
• Cross-matching ID:
  UNII: H57D26Z9YK
  DrugBank ID: DB13973
  TTD ID: D1U5BA
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01233960) Evaluation of PROCHYMAL for Treatment-refractory Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT02652130) Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD. U.S. National Institutes of Health.